Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards

GenapSys secures $90 million in bid to upend sequencing

By Tom Salemi | November 20, 2019

GenapSys Sequencer

GenapSys CEO says its Sequencer is a fraction of the size and cost of legacy systems. [Image courtesy of GenapSys]

Following the raising of a $90 million Series C, privately held GenapSys will begin rolling out a line of low cost electronic-based genetic sequencing machines that it says could upend the research and clinical testing industries.

CEO Hesaam Esfandyarpour says the Redwood City, Calif.–based company’s Sequencer, a table-top device that carries a price tag that’s about 1/100th of existing systems, will make will make genetic sequencing available to the vast majority of research institutions that can’t currently afford larger systems that can cost up to $1 million.

Get the full story on our sister site MassDevice. 

Tell Us What You Think! Cancel reply

Related Articles Read More >

FDA releases guidance to speed personalized drug development
Pigs
FDA OKs intentional genomic alteration in pigs — with potential therapeutic applications
Oxford Gene Technology
Oxford Gene Technology expands next-generation sequencing line
cleveland-clinic-disruptors-2021
The top 10 medical disruptors of 2021

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Drug Discovery and Development
  • Enews Signup
  • Contact Us
  • R&D World
  • Pharmaceutical Processing
  • Drug Delivery Business News

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards